REG - ValiRx PLC - Block listing Interim Review
RNS Number : 9213PValiRx PLC25 February 2021BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 25 February 2021
Name of applicant:
ValiRx plc
Name of scheme:
ValiRx plc Fundraise Warrants May 2020
Period of return:
From:
24 August 2020
To:
24 February 2021
Balance of unallotted securities under scheme(s) from previous return:
9,034,732
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Zero
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
8,951,399
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
83,333
Name of contact:
Kevin Alexander
Telephone number of contact:
+44 (0)2476 796496
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDBLRPPUGAPUPGGPP
Recent news on ValiRx
See all newsREG - ValiRx PLC - Directorate Changes
AnnouncementREG - ValiRx PLC - Evaluation Agreement with Imperial College London
AnnouncementREG - ValiRx PLC - Board Re-structuring and update on requisition
AnnouncementREG - ValiRx PLC - Shareholder Requisition Notice
AnnouncementREG - ValiRx PLC - Proposed Appointment of Non-Executive Director
Announcement